Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Humacyte Q2 2024 GAAP EPS $(0.48) Misses $(0.24) Estimate, Cash And Equivalents of $93.6M

Author: Benzinga Newsdesk | August 13, 2024 07:02am
Humacyte (NASDAQ:HUMA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.24) by 100 percent. This is a 118.18 percent decrease over losses of $(0.22) per share from the same period last year.

Posted In: HUMA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist